本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

77.51
-0.1900-0.24%
盤後77.510.00000.00%19:53 EDT
成交量:91.78萬
成交額:7,095.87萬
市值:150.26億
市盈率:-20.51
高:78.45
開:77.21
低:76.28
收:77.70
52周最高:84.94
52周最低:31.77
股本:1.94億
流通股本:1.51億
量比:0.46
換手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):-3.7800
每股收益(LYR):-3.7850
淨資產收益率:-1789.67%
總資產收益率:-33.83%
市淨率:-7.20
市盈率(LYR):-20.48

資料載入中...

2024/02/16

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/09

重要事件披露

Form 8-K - Current report
2024/01/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/25

重要事件披露

Form 8-K - Current report
2023/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities